Vyant Bio Reports Second Quarter and First Half 2022 Results and Provides Strategic and Business Highlights Conference Call and Webcast Today at 4:30 pm ET Scientific and Business Highlights Based on preclinical efficacy data in our human Rett cortical organoid model, we are advancing VYNT0126 into...

Burgeoning iPSC Global Market to Strike Double-Digit Growth (11.6% CAGR) Wellesley, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Since the discovery of induced pluripotent stem cell (iPSC) technology, the market has become an important part of the life sciences industry....